Health & Diseases

Thrombosis in Dogs: Blood Clots, Risk Factors, and Treatment

A thrombosis is the formation of a blood clot (thrombus) inside a blood vessel. Unlike physiological clotting after injury, the thrombus forms without external injury and blocks blood flow. If the clot detaches and travels to other vessels, it is called a thromboembolism.

Thrombosis in Dogs: Blood Clots, Risk Factors, and Treatment

What is thrombosis in dogs?

Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel—unlike physiological clotting following an injury, the thrombus forms without any external injury and blocks blood flow. If the clot breaks loose and travels to other vessels, this is referred to as thromboembolism.

In dogs, thrombosis is usually the result of an underlying condition that pathologically activates blood clotting. It can affect arterial vessels (causing acute symptoms due to ischemia) or venous vessels (with a slower progression). The most dangerous forms are pulmonary embolism and aortic thrombosis.

Background + Scientific Context

Ettinger et al. (2017, *Textbook of Veterinary Internal Medicine*, 8th ed.) describe Virchow’s triad as the basis for thrombotic diseases in dogs—three factors contribute to thrombus formation: damage to the vessel wall, slowed blood flow (stasis), and hypercoagulability. Diseases that induce hypercoagulability: protein-losing nephropathy (PLN) due to loss of anticoagulants (antithrombin III) in the urine; protein-losing enteropathy (PLE) via a similar mechanism; hyperadrenocorticism (Cushing’s syndrome) due to increased production of clotting factors; neoplasms; sepsis; Cardiac diseases with reduced blood flow. Immune-mediated hemolytic anemia (IMHA) is the most common underlying condition in canine thromboembolism.

Hogan and Brainard (2015, Veterinary Clinics of North America, https://pubmed.ncbi.nlm.nih.gov/26188483/) describe thromboembolic complications and prevention: Dogs with cardiac disease (dilated cardiomyopathy, atrial fibrillation) are at risk for thromboembolism due to intracardiac stasis. Aortic thrombosis (saddle thrombosis) is less common in dogs than in cats, but has been described in dogs with underlying heart disease. Clinical signs of aortic thrombosis: acute hindlimb paralysis, cold extremities, cries of pain. Treatment: immediate anticoagulation (heparin), thrombolysis for fresh thrombi in specialized centers.

Bruchim et al. (2008, Journal of Veterinary Emergency and Critical Care, https://pubmed.ncbi.nlm.nih.gov/18947488/) described the diagnosis and treatment of naturally occurring disseminated intravascular coagulation (DIC) in dogs: DIC is a life-threatening coagulation disorder characterized by the simultaneous occurrence of microthrombosis and consumptive coagulopathy (bleeding tendency). Causes: sepsis, trauma, heatstroke, parvovirus, neoplasia. Laboratory diagnosis: prolonged clotting times (PT, aPTT), thrombocytopenia, elevated D-dimer levels, hypofibrinogenemia. Treatment: treat the underlying disease, plasma transfusion (coagulation factors), cautious anticoagulation.

Vitomalia-Position

Thrombosis is a secondary condition—the underlying disease (IMHA, PLN, Cushing’s syndrome, neoplasia) is the primary focus of treatment. Anticoagulation is indicated for certain diagnoses and should be administered consistently. Thromboembolism, as a complication, is one of the most common causes of death in dogs with IMHA—prevention is a priority.

When does thrombosis become a concern?

  • IMHA diagnosis: Routine thromboprophylaxis with clopidogrel or heparin
  • Protein-losing nephropathy (PLN): Monitor antithrombin III levels
  • Cushing's syndrome (HAC): increased risk of thrombosis — coagulation monitoring
  • Symptoms of aortic thrombosis: acute hind limb paralysis, medical emergency
  • Suspected DIC: Intensive Care Unit — DIC is a medical emergency

Practical application

Underlying conditions associated with an increased risk of thrombosis in dogs:

Illness Mechanism Action
DESTROY Hypercoagulability caused by inflammation Clopidogrel, low-molecular-weight heparin
Protein-losing nephropathy Antithrombin III loss in urine Thromboprophylaxis, Diet
Hyperadrenocorticism Increased synthesis of clotting factors Monitoring, and heparin if necessary
Dilated cardiomyopathy Blood stasis in dilated chambers Heart treatment, aspirin/clopidogrel
Neoplasms Tumor-induced coagulation Treat the underlying condition

Anticoagulation options for dogs: - Unfractionated heparin (UFH): IV/SC, short duration of action, used in intensive care units - Low-molecular-weight heparin (LMWH, e.g., dalteparin): subcutaneous injection, suitable for outpatient use - Clopidogrel: antiplatelet agent, standard prophylaxis for IMHA - Aspirin: historically used, but now largely replaced by clopidogrel

Common Mistakes & Myths

  • “Thrombosis occurs without an underlying condition.” Idiopathic thrombosis is rare in dogs. There is almost always an underlying condition that triggers it—and diagnosing and treating that condition is the goal.
  • “Heparin treats thrombosis.” Heparin prevents the thrombus from growing further and stops new clots from forming—it does not dissolve existing clots. Thrombolysis (activator infusion) is only available at specialized centers for acute embolisms.
  • “DIC is immediately apparent.” DIC may initially present as a hypercoagulable phase (thrombosis) before consumptive coagulopathy (bleeding) becomes apparent. Laboratory testing is essential.

Current State of Research (2026)

Thromboembolism in dogs is an active area of research, particularly with regard to improving prophylaxis in IMHA and other hypercoagulable states. New anticoagulants (rivaroxaban, apixaban—factor Xa inhibitors) are being studied in dogs and are in use in some countries. D-dimer testing as a point-of-care test for thrombosis screening is well established. DIC management protocols are becoming increasingly standardized.

Frequently Asked Questions

What are the signs of thrombosis in dogs?

Depending on the location: acute hindlimb paralysis and cold extremities (aortic thrombosis), sudden shortness of breath (pulmonary embolism), neurological deficits (cerebral embolism). Often has an acute onset without warning.

Which dogs are at increased risk of thrombosis?

Dogs with IMHA, protein-losing nephropathy, Cushing’s syndrome, dilated cardiomyopathy, or certain tumors. For these underlying conditions, thromboprophylaxis is standard medical practice.

Can thrombosis in dogs be cured?

Depending on the location, extent, and underlying condition. Peripheral thromboses with good collateral circulation: recovery is often possible. Pulmonary embolism and aortic thrombosis have poorer prognoses. Treatment of the underlying condition is crucial.

Related terms

Sources & Further Reading

  1. Ettinger, S. J., Feldman, E. C., & Côté, E. (Eds.) (2017). Textbook of Veterinary Internal Medicine (8th ed.). Saunders. ISBN 9780323312110.

  2. Hogan, D. F., & Brainard, B. M. (2015). Cardiogenic embolism in the dog. Veterinary Clinics of North America: Small Animal Practice, 45(5), 1065–1082. https://pubmed.ncbi.nlm.nih.gov/26188483/

  3. Bruchim, Y., Aroch, I., Saragusty, J., & Waner, T. (2008). Disseminated intravascular coagulation. Journal of Veterinary Emergency and Critical Care, 18(5), 488–500. https://pubmed.ncbi.nlm.nih.gov/18947488/

Wissenschaftliche Einordnung

Ettinger et al. (2017, Textbook of Veterinary Internal Medicine, 8th ed.) describe Virchow's Triad as the basis of thrombotic diseases in dogs—three factors promote thrombus formation: vascular wall damage, slowed blood flow (stasis), and hypercoagulability. Diseases that induce hypercoagulability include: protein-losing nephropathy (PLN) due to loss of anticoagulants (antithrombin III) in the urine; protein-losing enteropathy (PLE) by a similar mechanism; hyperadrenocorticism (Cushing's syndrome) due to increased coagulation factor production; neoplasia; sepsis; and heart disease with reduced blood flow. Immune-mediated hemolytic anemia (IMHA) is the most common underlying disease in canine thromboembolism.

Hogan and Brainard (2015, Veterinary Clinics of North America, https://pubmed.ncbi.nlm.nih.gov/26188483/) describe thromboembolic complications and prevention: Dogs with cardiac diseases (dilated cardiomyopathy, atrial fibrillation) are at risk of thromboembolism due to intracardiac stasis. Aortic thrombosis (saddle thrombus) is less common in dogs than in cats, but has been described in cases of underlying cardiac disease. Clinical signs of aortic thrombosis: acute hindlimb paralysis, cold extremities, crying due to pain. Treatment: immediate anticoagulation (heparin), thrombolysis for fresh thrombi in specialized centers.

Bruchim et al. (2008, Journal of Veterinary Emergency and Critical Care, https://pubmed.ncbi.nlm.nih.gov/18947488/) described the diagnosis and treatment of naturally occurring disseminated intravascular coagulopathy (DIC) in dogs: DIC is a life-threatening coagulation disorder characterized by simultaneous microthrombosis and consumptive coagulopathy (bleeding tendency). Triggers: sepsis, trauma, heatstroke, parvovirus, neoplasia. Laboratory diagnosis: prolonged clotting times (PT, aPTT), thrombocytopenia, elevated D-dimer levels, hypofibrinogenemia. Treatment: treat the underlying disease, plasma transfusion (coagulation factors), careful anticoagulation.